MACFOS
|
|
BOM : 543787     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Feb 21,2025 |
Price(EOD): ₹ 818.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Trading |
MCap: ₹ 769.81 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
MACFOS | 10% | -28.2% | 77.4% |
ADANI ENTERPRISES | -4.1% | -7.9% | -32.4% |
REDINGTON | 3.4% | 12.7% | 21.9% |
MMTC | 0% | -18.6% | -32.1% |
HONASA CONSUMER | 0.1% | -8.2% | -47.3% |
LLOYDS ENTERPRISES | 11.6% | -15.7% | 27.9% |
ENTERO HEALTHCARE SOLUTIONS | 5.5% | 0.7% | 11.9% |
OPTIEMUS INFRACOM | -4.8% | -24.5% | 65.9% |
POLO QUEEN INDUSTRIAL & FINTECH | -0.5% | -7.4% | 222.3% |
FUNDAMENTAL ANALYSIS OF MACFOS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF MACFOS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
43.94
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 17.55 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 28.23
P/B Calculated based on Book Value of Rs 27.32 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.3
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 233.40 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
1472% 1098% -14% |
SHARE PRICE MOMENTUM OF MACFOS
MACFOS vs SENSEX
DEBT OF MACFOS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.3 0.39 0.66 0.45 |
0.3 - - 0.1 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF MACFOS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF MACFOS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-49.03% -58.02% -56.22% -56.05% |
46.58% -1.27% 5.07% 10.4% |
QtrlyTrend |
-2 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
MACFOS related INDICES
You may also like the below Video Courses
FAQ about MACFOS
Is MACFOS good for long term investment?
As on Feb 21,2025, the Fundamentals of MACFOS look Poor and hence it may not be good for long term investment ! See Financial Performance of MACFOS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is MACFOS UnderValued or OverValued?
As on Feb 21,2025, MACFOS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of MACFOS ?
As on Feb 21,2025, the Intrinsic Value of MACFOS is Rs. 68.37 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 52.09
Fair Value [Median EV / Sales Model] : Rs. 68.37
Fair Value [Median Price / Sales Model] : Rs. 955.36
Estimated Median Fair Value of MACFOS : Rs. 68.37
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is MACFOS trading at a Premium or Discount?
As on Feb 21,2025, MACFOS is trading at a Premium of 1098% based on the estimates of Median Intrinsic Value!ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs ENTERO HEALTHCARE SOLUTIONS LTD